August 16, 2023 PAO-08-23-PATV-02
From optimized tech transfer, to expedited batch release, to a team culture of expertise, David King, Director of Drug Product Operations at Samsung Biologics, will discuss pivotal moments in past projects and how Samsung Biologics leverages its CDMO expertise to meet accelerated timelines in aseptic fill/finish manufacturing.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.